A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Name: A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
Published: 2026
License: Public Domain

Shenzhen Shenxin Biotechnology Co., Ltd · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

herpes-zoster infectious messenger-rna mrna-vaccine safety vaccine

herpes zoster, in001, mrna vaccine, vaccine, varicella-zoster virus, vzv, viral diseases, shingles, messenger rna, herpes zoster (hz), skin diseases, infectious, safety

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 856924
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.